Initiated a formal process to monetize assets Implemented a restructuring plan to significantly reduce operating expenses and ...

Researchers at the University of Wisconsin School of Veterinary Medicine have identified a possible way to make ...

In a mouse study, scientists found that a bacterial sugar can be exploited to disable dangerous antibiotic-resistant ...

M&M’s are being urgently recalled in the UK over a dangerous health risk that could prove fatal to anyone with a peanut ...

The immune system going rogue and attacking healthy tissue seems to behind some cases of long covid, a discovery that could ...

HAVING a certain blood type could raise your risk of type 2 diabetes by up 28 per cent, research shows. Diabetes is caused by ...

LUND, SE / ACCESS Newswire / March 31, 2026 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and first-in-class ...

Royalty Pharma has made another play in the autoimmune space, this time crowning Johnson & Johnson as the beneficiary. Royalty and J&J have agreed to co-fund the development of a chronic autoimmune ...

Nina Notman meets the scientists developing recombinant antivenoms and small molecule inhibitors to save the lives and limbs of snakebite patients, who number in the their hundreds of thousands ...

A recent case of a man wrongly treated for HIV for seven years has raised concerns about testing accuracy. Experts explain how HIV tests work, why errors are rare, and what you should do if ...

Short seller's Characterization of ASCENIV's Competitive Position Reflects Blatant Misunderstanding of ADMA's Business and Its Role as Late-line Therapy for Patients Who are Immune Compromised and ...